Ablation for premature heartbeats with unknown cause
Part of Heart & circulation clinical trials.
This trial studies how well a procedure called ablation works for people with a specific type of extra heartbeat that comes from one spot in the heart and has no clear underlying cause. It looks at what predicts success in the short term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have frequent extra heartbeats that all look the same and come from one place in your heart.
- Your extra heartbeats are 'idiopathic', meaning doctors haven't found a clear cause like heart disease or another condition.
- You are scheduled for or considering an ablation procedure to treat these extra heartbeats.
- You do not have heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a customized treatment plan for people who have premature ventricular beats (PVCs) and have been referred for a procedure called PVC ablation. It may help doctors choose the best approach for stopping these extra heartbeats.
This study uses a special ultrasound camera on a thin tube inside your heart (intracardiac echocardiography) to help doctors see the area causing your heart rhythm problem more clearly during the standard procedure (ablation). It may help them burn the wrong tissue more precisely.
This study compares two treatments for people with frequent extra heartbeats (PVCs): a procedure called catheter ablation or medications. It aims to find which works better and has fewer side effects.
This trial tests a new way to treat rapid heartbeats from the lower chambers (ventricles) using a special catheter that delivers short electrical pulses to stop the abnormal signals. It may help people with extra beats (PVCs) or a fast heart rhythm (ventricular tachycardia) that needs treatment.
This trial is testing a new type of energy called pulsed field ablation (PFA) to treat extra heartbeats (premature ventricular contractions or PVCs). It looks at how well this procedure works and how safe it is over at least 3 months.
This trial studies how a drug called adenosine helps doctors understand why premature ventricular contractions (PVCs) are happening. The goal is to guide treatment, including catheter ablation, for people with PVCs.
Hear when a new Arrythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.